Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2024-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Wellbiotec Co., Ltd., covering the period from January 1, 2024, to June 30, 2024. It contains detailed corporate information, business descriptions, capital structure, and governance details, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself, containing substantive financial and operational data. H1 2024
2024-08-14 Korean
기타안내사항(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory announcement from Well Biotech regarding the expiration of a lock-up period (protective custody) for shares issued via third-party allocation. It does not fit into specific categories like M&A, dividends, or financial reports. As it is a general regulatory disclosure regarding share status and capital structure, it falls under the fallback category of Regulatory Filings (RNS).
2024-06-25 Korean
횡령ㆍ배임혐의발생
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure regarding a legal matter involving allegations of embezzlement and breach of trust against a former executive. It details the nature of the incident, the amount involved, and the company's planned response. Since this relates to significant legal proceedings and regulatory disclosure requirements, it falls under the 'Legal Proceedings Report' category.
2024-06-24 Korean
소송등의제기ㆍ신청(경영권분쟁소송)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a legal proceeding ('소송 등의 제기ㆍ신청') involving a management dispute ('경영권 분쟁 소송'). It details a court filing for the inspection of books and records ('장부등열람허용가처분') against the company. Since this document specifically reports on a lawsuit and legal action, it falls under the 'Legal Proceedings Report' category.
2024-06-13 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Wellbiotec Co., Ltd. covering the period from January 1, 2024, to March 31, 2024. It contains detailed corporate information, financial data, management discussion, and governance details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
기타시장안내 (개선기간 부여)
Delisting Announcement Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding a listed company, Wellbiotech, concerning the granting of an improvement period following a 'disclaimer of opinion' in their audit report. This is a regulatory announcement regarding market status and listing rules, which does not fit into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a Regulatory Filing (RNS).
2024-05-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.